Impacts of Eligibility Criteria on Trial Participants' Age in Alzheimer's Disease Clinical Trials. - Aokun Chen; Qian Li 034; Xing He 003; Michael Jaffee; William R. Hogan; Fei Wang 001; Yi Guo 005; Jiang Bian 001 (AMIA, 2022)

Identifying progression subphenotypes of Alzheimer's disease from large-scale electronic health records with machine learning. - Manqi Zhou; Alice S. Tang; Hao Zhang; Zhenxing Xu; Alison M. C. Ke; Chang Su; Yu Huang 018; William G. Mantyh; Michael Jaffee; Katherine P. Rankin; Steven DeKosky; Jiayu Zhou; et al. (J. Biomed. Informatics, 2025)